Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype

Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2012-10, Vol.36 (7), p.627-634
Hauptverfasser: Sugimoto, M., Shirai, N., Nishino, M., Kodaira, C., Uotani, T., Yamade, M., Sahara, S., Ichikawa, H., Sugimoto, K., Miyajima, H., Furuta, T.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 634
container_issue 7
container_start_page 627
container_title Alimentary pharmacology & therapeutics
container_volume 36
creator Sugimoto, M.
Shirai, N.
Nishino, M.
Kodaira, C.
Uotani, T.
Yamade, M.
Sahara, S.
Ichikawa, H.
Sugimoto, K.
Miyajima, H.
Furuta, T.
description
doi_str_mv 10.1111/apt.12014
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_apt_12014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_apt_12014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c744-86ae2267cae4e484e15cdfa4149614227ff4acf707a1ebd71fb1dedd97ab230c3</originalsourceid><addsrcrecordid>eNpN0E9KxDAUx_EgCo6jC2_wtoKtSZpppksp_oMBRWbjqrymr53ItKlJEcaVR_ACgmfxKJ7E6rjwbd7u84MvY8eCx2K8M-yHWEgu1A6biCSdRZIn6S6bcJlmkZyLZJ8dhPDIOU81lxP2fo8l9R5f3JpA8M-PtoGnuIpDDBUZTxgogFRfr28rsN3gscEweGsAja3ssIFgm87W1mA3rDfQOk8wrLAD_8-VHEa2HFlwHtR2xcVtfArumbxxre0ayB_uQEIOIoOGOjdsejpkezWuAx39_SlbXl4s8-tocXt1k58vIqOViuYpkpSpNkiK1FyRmJmqRiVUlgolpa5rhabWXKOgstKiLkVFVZVpLGXCTTJlJ1vWeBeCp7rovW3RbwrBi5-sxZi1-M2afAMNrWzq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Sugimoto, M. ; Shirai, N. ; Nishino, M. ; Kodaira, C. ; Uotani, T. ; Yamade, M. ; Sahara, S. ; Ichikawa, H. ; Sugimoto, K. ; Miyajima, H. ; Furuta, T.</creator><creatorcontrib>Sugimoto, M. ; Shirai, N. ; Nishino, M. ; Kodaira, C. ; Uotani, T. ; Yamade, M. ; Sahara, S. ; Ichikawa, H. ; Sugimoto, K. ; Miyajima, H. ; Furuta, T.</creatorcontrib><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.12014</identifier><language>eng</language><ispartof>Alimentary pharmacology &amp; therapeutics, 2012-10, Vol.36 (7), p.627-634</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c744-86ae2267cae4e484e15cdfa4149614227ff4acf707a1ebd71fb1dedd97ab230c3</citedby><cites>FETCH-LOGICAL-c744-86ae2267cae4e484e15cdfa4149614227ff4acf707a1ebd71fb1dedd97ab230c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Sugimoto, M.</creatorcontrib><creatorcontrib>Shirai, N.</creatorcontrib><creatorcontrib>Nishino, M.</creatorcontrib><creatorcontrib>Kodaira, C.</creatorcontrib><creatorcontrib>Uotani, T.</creatorcontrib><creatorcontrib>Yamade, M.</creatorcontrib><creatorcontrib>Sahara, S.</creatorcontrib><creatorcontrib>Ichikawa, H.</creatorcontrib><creatorcontrib>Sugimoto, K.</creatorcontrib><creatorcontrib>Miyajima, H.</creatorcontrib><creatorcontrib>Furuta, T.</creatorcontrib><title>Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype</title><title>Alimentary pharmacology &amp; therapeutics</title><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpN0E9KxDAUx_EgCo6jC2_wtoKtSZpppksp_oMBRWbjqrymr53ItKlJEcaVR_ACgmfxKJ7E6rjwbd7u84MvY8eCx2K8M-yHWEgu1A6biCSdRZIn6S6bcJlmkZyLZJ8dhPDIOU81lxP2fo8l9R5f3JpA8M-PtoGnuIpDDBUZTxgogFRfr28rsN3gscEweGsAja3ssIFgm87W1mA3rDfQOk8wrLAD_8-VHEa2HFlwHtR2xcVtfArumbxxre0ayB_uQEIOIoOGOjdsejpkezWuAx39_SlbXl4s8-tocXt1k58vIqOViuYpkpSpNkiK1FyRmJmqRiVUlgolpa5rhabWXKOgstKiLkVFVZVpLGXCTTJlJ1vWeBeCp7rovW3RbwrBi5-sxZi1-M2afAMNrWzq</recordid><startdate>201210</startdate><enddate>201210</enddate><creator>Sugimoto, M.</creator><creator>Shirai, N.</creator><creator>Nishino, M.</creator><creator>Kodaira, C.</creator><creator>Uotani, T.</creator><creator>Yamade, M.</creator><creator>Sahara, S.</creator><creator>Ichikawa, H.</creator><creator>Sugimoto, K.</creator><creator>Miyajima, H.</creator><creator>Furuta, T.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201210</creationdate><title>Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype</title><author>Sugimoto, M. ; Shirai, N. ; Nishino, M. ; Kodaira, C. ; Uotani, T. ; Yamade, M. ; Sahara, S. ; Ichikawa, H. ; Sugimoto, K. ; Miyajima, H. ; Furuta, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c744-86ae2267cae4e484e15cdfa4149614227ff4acf707a1ebd71fb1dedd97ab230c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugimoto, M.</creatorcontrib><creatorcontrib>Shirai, N.</creatorcontrib><creatorcontrib>Nishino, M.</creatorcontrib><creatorcontrib>Kodaira, C.</creatorcontrib><creatorcontrib>Uotani, T.</creatorcontrib><creatorcontrib>Yamade, M.</creatorcontrib><creatorcontrib>Sahara, S.</creatorcontrib><creatorcontrib>Ichikawa, H.</creatorcontrib><creatorcontrib>Sugimoto, K.</creatorcontrib><creatorcontrib>Miyajima, H.</creatorcontrib><creatorcontrib>Furuta, T.</creatorcontrib><collection>CrossRef</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugimoto, M.</au><au>Shirai, N.</au><au>Nishino, M.</au><au>Kodaira, C.</au><au>Uotani, T.</au><au>Yamade, M.</au><au>Sahara, S.</au><au>Ichikawa, H.</au><au>Sugimoto, K.</au><au>Miyajima, H.</au><au>Furuta, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><date>2012-10</date><risdate>2012</risdate><volume>36</volume><issue>7</issue><spage>627</spage><epage>634</epage><pages>627-634</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><doi>10.1111/apt.12014</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (7), p.627-634
issn 0269-2813
1365-2036
language eng
recordid cdi_crossref_primary_10_1111_apt_12014
source Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
title Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T03%3A13%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rabeprazole%2010%C2%A0mg%20q.d.s.%20decreases%2024%E2%80%90h%20intragastric%20acidity%20significantly%20more%20than%20rabeprazole%2020%20mg%20b.d.%20or%2040%C2%A0mg%20o.m.,%20overcoming%20CYP%202%20C%2019%20genotype&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Sugimoto,%20M.&rft.date=2012-10&rft.volume=36&rft.issue=7&rft.spage=627&rft.epage=634&rft.pages=627-634&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.12014&rft_dat=%3Ccrossref%3E10_1111_apt_12014%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true